KR20230060659A - Cosmetic composition for exfoliating and pad having the same - Google Patents
Cosmetic composition for exfoliating and pad having the same Download PDFInfo
- Publication number
- KR20230060659A KR20230060659A KR1020210145116A KR20210145116A KR20230060659A KR 20230060659 A KR20230060659 A KR 20230060659A KR 1020210145116 A KR1020210145116 A KR 1020210145116A KR 20210145116 A KR20210145116 A KR 20210145116A KR 20230060659 A KR20230060659 A KR 20230060659A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- exfoliation
- weight
- skin
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 101
- 239000002537 cosmetic Substances 0.000 title claims abstract description 92
- 238000004299 exfoliation Methods 0.000 claims abstract description 50
- 210000004927 skin cell Anatomy 0.000 claims abstract description 23
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 16
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 16
- 239000003381 stabilizer Substances 0.000 claims abstract description 14
- 150000007524 organic acids Chemical class 0.000 claims abstract description 9
- 150000001261 hydroxy acids Chemical class 0.000 claims abstract description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 20
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical group OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 19
- 229960000281 trometamol Drugs 0.000 claims description 19
- 102000011782 Keratins Human genes 0.000 claims description 18
- 108010076876 Keratins Proteins 0.000 claims description 18
- -1 capryloyl salicylic acid (Capryloyl Salicylic Acid) Chemical compound 0.000 claims description 5
- 208000007542 Paresis Diseases 0.000 claims 1
- 208000012318 pareses Diseases 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 abstract description 14
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 abstract description 7
- 206010040880 Skin irritation Diseases 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 230000036556 skin irritation Effects 0.000 abstract description 4
- 231100000475 skin irritation Toxicity 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 45
- 230000000052 comparative effect Effects 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000008213 purified water Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 230000005856 abnormality Effects 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229920005862 polyol Polymers 0.000 description 6
- 150000003077 polyols Chemical class 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000004383 yellowing Methods 0.000 description 5
- 150000001277 beta hydroxy acids Chemical class 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940100573 methylpropanediol Drugs 0.000 description 2
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 108010051489 calin Proteins 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 1
- 229940093767 glabridin Drugs 0.000 description 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- KONVNJDNYREFLP-UHFFFAOYSA-N octanoyl 2-hydroxybenzoate Chemical compound CCCCCCCC(=O)OC(=O)C1=CC=CC=C1O KONVNJDNYREFLP-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 각질제거용 화장료 조성물 관한 것으로, 구체적으로 고함량의 카프릴로일 살리실릭 애씨드를 포함하면서도 피부에 자극을 최소화하고, 피지 및 각질케어가 우수한 안정적인 각질제거용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for removing dead skin cells, and more specifically, to a cosmetic composition for removing dead skin cells that contains a high content of capryloyl salicylic acid while minimizing irritation to the skin and having excellent sebum and dead skin care properties.
인체를 이루고 있는 가장 큰 기관인 피부는 외부로부터 피부 안쪽의 다양한 기관을 보호하는 기능과 내부의 수분 및 유용 성분이 밖으로 유출되는 것을 막아주는 장벽기능, 온도조절 기능, 배설 기능, 호흡 기능 등 다양한 생리적 기능을 담당하고 있는 아주 중요한 기관이다. 그러나, 나이가 들면서 피부의 두께가 얇아져 피부 장벽 기능이 저하되고 피부의 수분함량의 급격한 감소로 피부가 건조 해지는 등 피부의 생리적 기능이 저하된다. 또한, 자외선량의 증가, 대기오염, 현대인의 과도한 피로와 스트레스 등으로 생성된 반응성이 높은 활성산소, 자유라디칼은 단백질, 핵산, 세포막 지질 등의 생체성분을 산화시키거나 변성시켜 피부의 생리적 기능 저하를 일으켜 외부의 작은 자극원에 의해서도 피부 자극이 쉽게 일어나게 한다. 아울러 피부의 노화에 따라 주름, 기미, 주근깨 및 색소 침착이 발생되는 등의 피부 자극 현상도 나타나고 있다. The skin, the largest organ that makes up the human body, has various physiological functions such as a function to protect various organs inside the skin from the outside, a barrier function to prevent internal moisture and useful ingredients from leaking out, a temperature control function, an excretion function, and a respiratory function. It is a very important organ responsible for However, with age, the thickness of the skin becomes thinner, and the skin barrier function is lowered, and the physiological function of the skin is lowered, such as dryness of the skin due to a rapid decrease in moisture content of the skin. In addition, highly reactive reactive oxygen species and free radicals generated by increased amounts of ultraviolet rays, air pollution, and excessive fatigue and stress of modern people oxidize or denature biocomponents such as proteins, nucleic acids, and cell membrane lipids, thereby reducing the physiological function of the skin. causes skin irritation to occur easily even by small external stimulants. In addition, skin irritation phenomena such as wrinkles, melasma, freckles, and pigmentation occur according to aging of the skin.
또한, 피부에서 피지의 생성은 피부의 보습 유지나 미생물의 침입을 막는 역할을 담당하지만, 피지의 과다한 분비는 피부의 번들거림이나 화장의 들뜸, 모공의 확대와 노화, 사춘기 이후 여드름의 생성 촉진 등을 유발하기도 한다. 이러한 피부질환을 치료하기 위하여 여러가지 물질들이 개발되어 왔으나, 근본원인을 제거하는 물질이기 보다는 여드름 등과 같은 증상이나 질환 자체의 치료를 목적으로 개발된 물질이기 때문에, 그 치유 효과가 미미하고 예방적 개념은 전무한 상황이며, 합성 약제에 의한 피부 발적, 피부과민 반응, 광과민 반응 등의 부작용 및 재발이 자주 발생하는 문제점들을 가지고 있다. In addition, the production of sebum in the skin plays a role in keeping the skin moisturized and preventing the invasion of microorganisms, but excessive secretion of sebum causes shine of the skin, lifting of makeup, enlargement and aging of pores, and promotion of acne after puberty. do it too Various substances have been developed to treat these skin diseases, but since they are substances developed for the purpose of treating symptoms such as acne or diseases themselves rather than substances that remove the root cause, the healing effect is insignificant and the concept of prevention is insignificant. There is no situation, and side effects such as skin redness, skin hypersensitivity reaction, and photosensitivity reaction caused by synthetic drugs and recurrence frequently occur.
이와 관련하여, AHA, BHA, PHA, LHA등의 다양한 유기산 조성물을 사용하여 피부 보습 효과, 세포 재생 효과, 미백효과, 주름개선효과, 피부 탄력효과를 위한 화장품 연구 및 개발이 이루어지고 있으며, 산도에 의한 피부 자극은 최소화하고 효과는 상승시키는 다양한 시도를 하고 있다. In this regard, research and development of cosmetics for skin moisturizing effect, cell regeneration effect, whitening effect, wrinkle improvement effect, and skin elasticity effect are being conducted using various organic acid compositions such as AHA, BHA, PHA, and LHA. Various attempts have been made to minimize skin irritation and increase the effect.
이에 따라, 본 발명자는 4세대 각질제거성분인 LHA를 이용하여 피부의 pH와 유사한 약산성의 환경에서 피부에 자극을 최소화하면서도 피지억제 기능이 우수한 안정성을 가지는 화장료 조성물을 개발하여 본 발명에 이르게 되었다. Accordingly, the present inventors have developed a cosmetic composition having excellent stability with a sebum-inhibiting function while minimizing irritation to the skin in a weakly acidic environment similar to the pH of the skin using LHA, a 4th generation exfoliating component, and led to the present invention.
본 발명은 LHA(Lipo Hydroxy Acid)를 포함하는 유기산 및 폴리에틸렌 글라이콜 에테르(Polyethylene Glycol Ether)를 포함하는 안정화제를 포함하는 각질제거용 화장료 조성물에 관한 것으로, 구체적으로 고함량의 카프릴로일 살리실릭 애씨드를 포함하면서도 피부에 자극을 최소화하고 피지 및 각질 케어가 우수한 안정적인 각질제거용 화장료 조성물을 제공하고자 한다. The present invention relates to a cosmetic composition for exfoliation comprising an organic acid including LHA (Lipo Hydroxy Acid) and a stabilizer including polyethylene glycol ether, and specifically, a high content of capryloyl salicylate. An object of the present invention is to provide a cosmetic composition for stable exfoliation, which includes silic acid, minimizes irritation to the skin, and provides excellent sebum and dead skin care.
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당 업계에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다. However, the technical problem to be achieved by the present invention is not limited to the above-mentioned problems, and other problems not mentioned will be clearly understood by those skilled in the art from the following description.
본 발명의 일 실시예에 따르면, LHA(Lipo Hydroxy Acid)를 포함하는 유기산 및 폴리에틸렌 글라이콜 에테르(Polyethylene Glycol Ether)를 포함하는 안정화제를 포함하는 각질제거용 화장료 조성물이 제공된다. According to one embodiment of the present invention, a cosmetic composition for exfoliation comprising an organic acid including LHA (Lipo Hydroxy Acid) and a stabilizer including polyethylene glycol ether is provided.
본 발명에서 상기 LHA는 상기 각질제거 화장료 조성물 전체 중량에 대하여, 0.2 내지 2 중량% 포함되는 각질제거용 화장료 조성물일 수 있다. In the present invention, the LHA may be a cosmetic composition for exfoliating keratin, which is contained in an amount of 0.2 to 2% by weight based on the total weight of the cosmetic composition for exfoliating keratin.
본 발명에서 상기 LHA는 카프릴로일 살리실릭 애씨드(Capryloyl Salicylic Acid)인 것을 특징으로 하는 각질제거용 화장료 조성물일 수 있다. In the present invention, the LHA may be a cosmetic composition for exfoliation, characterized in that capryloyl salicylic acid.
본 발명에서 상기 폴리에틸렌 글라이콜 에테르는 상기 각질제거 화장료 조성물 전체 중량에 대하여, 0.5 중량% 이상 포함되는 각질제거용 화장료 조성물일 수 있다. In the present invention, the polyethylene glycol ether may be a cosmetic composition for exfoliating keratin, which is included in an amount of 0.5% by weight or more based on the total weight of the cosmetic composition for exfoliating keratin.
본 발명에서 상기 폴리에틸렌 글라이콜 에테르는 C12-14 파레스-12인 것을 특징으로 하는 각질제거용 화장료 조성물일 수 있다. In the present invention, the polyethylene glycol ether may be a cosmetic composition for exfoliation, characterized in that C12-14 Phares-12.
본 발명에서 상기 안정화제는 디프로필렌 글라이콜(Dipropylene Glycol) 및 트로메타민(Tromethamine)으로 이루어진 그룹에서 선택되는 어느 하나 이상을 더 포함하는 각질제거용 화장료 조성물일 수 있다. In the present invention, the stabilizer is dipropylene glycol And tromethamine (Tromethamine) may be a cosmetic composition for exfoliation further comprising any one or more selected from the group consisting of.
본 발명에서 상기 디프로필렌 글라이콜은 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 7 중량% 이상으로 포함되는 각질제거용 화장료 조성물일 수 있다. In the present invention, the dipropylene glycol may be included in the cosmetic composition for exfoliation in an amount of 7% by weight or more based on the total weight of the cosmetic composition for exfoliation.
본 발명에서 상기 트로메타민은 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 0.12 중량% 이하로 포함되는 각질제거용 화장료 조성물일 수 있다. In the present invention, the tromethamine may be included in a cosmetic composition for removing dead skin cells in an amount of 0.12% by weight or less based on the total weight of the cosmetic composition for removing dead skin cells.
본 발명에서 상기 각질제거용 화장료 조성물은 pH 5 내지 6 인 것을 특징으로 하는 각질제거용 화장료 조성물일 수 있다. In the present invention, the cosmetic composition for exfoliation may be a cosmetic composition for exfoliation, characterized in that the pH is 5 to 6.
본 발명의 다른 실시예에 따르면, 상기 각질제거용 화장료 조성물 조성물을 포함하는 각질제거용 패드가 제공된다. According to another embodiment of the present invention, there is provided a pad for removing dead skin cells containing the cosmetic composition for removing dead skin cells.
본 발명에서 제공하는 각질제거용 화장료 조성물은 고함량의 카프릴로일살리실릭애씨드를 함유하면서도 피부에 자극을 최소화하고, 피지억제 및 각질케어의 기능이 우수할 뿐만 아니라, 우수한 안정성 및 보습감의 효과가 있다. The cosmetic composition for exfoliation provided in the present invention minimizes irritation to the skin while containing a high content of capryloyl salicylic acid, has excellent sebum inhibition and keratin care functions, and has excellent stability and moisturizing effect. there is.
도 1 내지 도 4는 본 발명의 비교예들에 따라 형성된 제형의 이미지를 나타낸 것이다. 1 to 4 show images of formulations formed according to comparative examples of the present invention.
이하, 보다 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 하기 실시예는 예시적인 것으로, 본 발명의 범위가 이에 제한되는 것은 아니다. Hereinafter, an example will be described in detail for a more detailed explanation. However, the following examples are illustrative, and the scope of the present invention is not limited thereto.
본 발명의 일 실시예에 따르면, LHA(Lipo Hydroxy Acid)를 포함하는 유기산 및 폴리에틸렌 글라이콜 에테르(Polyethylene Glycol Ether)를 포함하는 안정화제를 포함하는 각질제거용 화장료 조성물에 관한 것이다. According to one embodiment of the present invention, it relates to a cosmetic composition for exfoliation comprising an organic acid including LHA (Lipo Hydroxy Acid) and a stabilizer including polyethylene glycol ether.
상기 유기산은 유기 화합물 중 산성을 갖는 것을 뜻하며, 피부의 pH밸런스 조절, 피지 및 각질제거의 기능을 하고, 상기 안정화제는 상기 유기산 및 각질제거용 화장료 조성물들을 석출되지 않고 완전히 용해시키며, 목적하는 pH의 범위를 유지시켜 각질제거용 화장료 조성물로서 기능을 유지할 수 있도록 한다. The organic acid means having acidity among organic compounds, and functions to control the pH balance of the skin, remove sebum and dead skin cells, and the stabilizer completely dissolves the organic acid and cosmetic compositions for removing dead skin cells without precipitating them, and the desired pH By maintaining the range of, it is possible to maintain the function as a cosmetic composition for removing dead skin cells.
본 발명의 상기 LHA는 상기 각질제거 화장료 조성물 전체 중량에 대하여, 0.2 중량% 내지 2 중량% 포함되는 각질제거용 화장료 조성물 일 수 있으나, 이에 제한되지 않는다. The LHA of the present invention may be a cosmetic composition for exfoliating keratin, which is contained in an amount of 0.2% to 2% by weight based on the total weight of the cosmetic composition for exfoliating keratin, but is not limited thereto.
본 발명에서 상기 LHA는 상기 각질제거용 화장료 조성물 총 중량에 대하여 0.2 중량% 내지 2 중량% 포함될 수 있고, 상기 LHA가 0.2 중량% 미만으로 포함되는 경우 목적하는 pH의 범위를 형성하지 못하여 피지 및 각질케어의 효능이 미비하여, 2 중량%를 초과하는 경우 피부에 자극을 주는 문제점이 발생할 수 있기에 목적하는 pH의 범위를 유지하면서 각질제거용 화장료 조성물로써 기능을 증진시키기 위한 측면에서 가장 적합하게는 0.22 중량% 포함될 수 있으나 이에 제한되지 않는다. In the present invention, the LHA may be included in an amount of 0.2% to 2% by weight based on the total weight of the cosmetic composition for removing dead skin cells. Since the efficacy of the care is insufficient, if it exceeds 2% by weight, a problem of irritating the skin may occur, so it is most suitable in terms of enhancing the function as a cosmetic composition for exfoliation while maintaining the desired pH range 0.22 Weight % may be included, but is not limited thereto.
상기 LHA(Lipo Hydroxy Acid)는 유기산의 일종으로 BHA(β-Hydroxy acid)의 살리실릭 애씨드 유도체를 사용함으로써 BHA에서 파생된 것으로, BHA의 분자구조에 탄소 지방 사슬 8개가 추가되어 더욱 높은 친유성으로 피부에 안정성을 주면서 피지 및 각질제거가 가능하다. The LHA (Lipo Hydroxy Acid) is a kind of organic acid derived from BHA by using a salicylic acid derivative of BHA (β-Hydroxy acid). It is possible to remove sebum and dead skin while giving stability to the skin.
본 발명의 상기 LHA는 불필요한 과잉각질만을 제거하여 피부에 최소한의 자극으로 주면서 피지 및 각질제거의 기능을 증진시키는 측면에서 카프릴로일 살리실릭 애씨드(Capryloyl Salicylic Acid)인 것을 특징으로 하는 각질제거용 화장료 조성물일 수 있으나, 이에 제한되지 않는다. The LHA of the present invention is a cosmetic for removing dead skin cells, characterized in that it is Capryloyl Salicylic Acid in terms of enhancing the function of removing sebum and dead skin cells while providing minimal irritation to the skin by removing only unnecessary excess dead skin cells. It may be a composition, but is not limited thereto.
본 발명의 상기 폴리에틸렌 글라이콜 에테르는 상기 각질제거 화장료 조성물 전체 중량에 대하여, 0.5 중량% 이상 포함되는 각질제거용 화장료 조성물일 수 있으나, 이에 제한되지 않는다. The polyethylene glycol ether of the present invention may be a cosmetic composition for exfoliating keratin, which is contained in an amount of 0.5% by weight or more based on the total weight of the cosmetic composition for exfoliating keratin, but is not limited thereto.
본 발명에서 상기 폴리에틸렌 글라이콜 에테르는 상기 각질제거용 화장료 조성물 총 중량에 대하여 0.5 중량% 내지 2 중량% 포함될 수 있다. 상기 폴리에틸렌 글라이콜 에테르가 상기 각질제거용 화장료 조성물 총 중량에 대하여 0.5 중량% 미만으로 포함되는 경우, 상기 LHA가 완전히 용해되지 않아 정제수와 만날 경우 석출 되면서 완전하게 분리되어 화장료 조성물로서 형성이 어려운 문제점이 있고, 2중량% 초과로 포함되는 경우, 0.5 중량% 이상 내지 2중량% 이하로 포함되는 경우와 효과의 차이가 현저하지 않기에 생산성 및 경제적으로 효율적인 측면에서 가장 적합하게는 0.5 중량% 내지 1중량%로 포함될 수 있으나, 이에 제한되지 않는다.In the present invention, the polyethylene glycol ether may be included in an amount of 0.5% to 2% by weight based on the total weight of the cosmetic composition for exfoliation. When the polyethylene glycol ether is included in less than 0.5% by weight based on the total weight of the cosmetic composition for exfoliation, the LHA is not completely dissolved and precipitates when it meets purified water, and is completely separated, making it difficult to form a cosmetic composition. And, when it is included in more than 2% by weight, the difference between the effect is not significant when it is included in 0.5% by weight or more to 2% by weight or less, so it is most suitable from 0.5% by weight to 1% in terms of productivity and economical efficiency. It may be included in weight percent, but is not limited thereto.
본 발명의 상기 폴리에틸렌 글라이콜 에테르는 C12-14 파레스-12, 피이지-40하이드로제네이티드캐스터오일, 피이지-60하이드로제네이티드캐스터오일로 이루어진 그룹에서 선택되는 어느 하나 이상을 더 포함할 수 있고, 목적하는 pH의 범위를 유지하면서도 LHA가 완전히 용해되어 안정적인 각질제거용 화장료 조성물을 유지하는 측면에서 C12-14 파레스-12인 것을 특징으로 하는 각질제거용 화장료 조성물일 수 있으나 이에 제한되지 않는다. The polyethylene glycol ether of the present invention may further contain at least one selected from the group consisting of C12-14 Pareth-12, PEG-40 Hydrogenated Castor Oil, and PEG-60 Hydrogenated Castor Oil. In addition, in terms of maintaining a stable cosmetic composition for exfoliation in which LHA is completely dissolved while maintaining the desired pH range, it may be a cosmetic composition for exfoliation, characterized in that it is C12-14 Phares-12, but is not limited thereto.
본 발명의 상기 안정화제는 디프로필렌 글라이콜(Dipropylene Glycol) 및 트로메타민(Tromethamine)으로 이루어진 그룹에서 선택되는 어느 하나 이상을 더 포함하는 각질제거용 화장료 조성물일 수 있으나, 이에 제한되지 않는다. The stabilizer of the present invention is dipropylene glycol And it may be a cosmetic composition for exfoliation further comprising at least one selected from the group consisting of tromethamine, but is not limited thereto.
본 발명의 상기 디프로필렌 글라이콜은 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 7 중량% 이상 포함되는 각질제거용 화장료 조성물일 수 있으나, 이에 제한되지 않는다. The dipropylene glycol of the present invention may be a cosmetic composition for removing keratin, which is contained in an amount of 7% by weight or more based on the total weight of the cosmetic composition for keratin removal, but is not limited thereto.
본 발명에서 상기 디프로필렌 글라이콜는 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 7 중량% 이상 내지 10중량% 이하로 포함되는 각질제거용 화장료 조성물일 수 있다. 상기 디프로필렌 글라이콜이 상기 각질제거용 화장료 조성물 전체 중량에 대하여 7 중량% 미만으로 포함되는 경우, 상기 LHA가 완전히 용해되지 않아 정제수와 만날 경우 석출 되면서 완전하게 분리되어 화장료 조성물로서 형성이 어려운 문제점이 있고, 10중량% 초과로 포함되는 경우 7 중량% 이상 내지 10중량% 이하로 포함되는 경우와 효과의 차이가 현저하지 않기에 생산성 및 경제적으로 효율적인 측면에서 가장 적합하게는 7 중량% 내지 8중량%로 포함될 수 있으나, 이에 제한되지 않는다.In the present invention, the dipropylene glycol may be included in a cosmetic composition for removing dead skin cells in an amount of 7% by weight or more to 10% by weight or less based on the total weight of the cosmetic composition for removing dead skin cells. When the dipropylene glycol is contained in less than 7% by weight based on the total weight of the cosmetic composition for exfoliation, the LHA is not completely dissolved and precipitates when it meets purified water, and is completely separated, making it difficult to form a cosmetic composition. And, when it is included in more than 10% by weight, there is no significant difference in effect from when it is included in 7% by weight or more to 10% by weight or less, so it is most suitable from 7% to 8% by weight in terms of productivity and economical efficiency. %, but is not limited thereto.
본 발명의 상기 트로메타민은 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 0.18 중량%, 0.17 중량%, 0.15 중량%, 0.13 중량%, 0.11 중량% 이하로 포함되는 각질제거용 화장료 조성물일 수 있으며, 목적하는 pH의 범위를 유지하여 각질제거 효능을 항샹시키는 측면에서 가장 적합하게 0.11 중량% 포함될 수 있으나, 이에 제한되지 않는다. The tromethamine of the present invention may be a cosmetic composition for exfoliation containing 0.18% by weight, 0.17% by weight, 0.15% by weight, 0.13% by weight, or 0.11% by weight or less, based on the total weight of the cosmetic composition for exfoliation. , In terms of maintaining the desired pH range to enhance the exfoliation efficacy, it may be most suitably included at 0.11% by weight, but is not limited thereto.
본 발명에서 상기 트로메타민이 상기 각질제거용 화장료 조성물 전체 중량에 대하여 0.18 중량%를 초과하는 경우, 목적하는 pH의 범위를 벗어나고 미세황변이 발생되며 안정성이 낮아지는 문제점이 있다. In the present invention, when the tromethamine exceeds 0.18% by weight based on the total weight of the cosmetic composition for exfoliation, there are problems in that the pH is out of the desired range, micro-yellowing occurs, and stability is lowered.
본 발명의 상기 각질제거용 화장료 조성물은, pH 5 내지 6, pH 5.1 내지 5.9, pH 5.2 내지 5.9, pH 5.3 내지 5.8 및 pH 5.4 내지 5.8 인 것이 특징일 수 있고, 피부에 주는 자극을 최소화하면서도 피지 및 각질케어 기능을 우수하게 하는 측면에서 가장 적합하게는 pH 5.5 내지 5.7 인 것을 특징으로 하는 각질제거용 화장료 조성물일 수 있으나 이에 제한되지 않는다. The cosmetic composition for exfoliation of the present invention may be characterized by
본 발명에서 상기 각질제거용 화장료 조성물의 pH 값이 5 미만인 경우 피부에 자극을 줄 수 있고, pH 값이 6을 초과하는 경우 각질 제거의 효능이 약해지는 문제점이 있다. In the present invention, when the pH value of the cosmetic composition for exfoliation is less than 5, it may irritate the skin, and when the pH value exceeds 6, there is a problem in that the efficacy of exfoliation is weakened.
본 발명의 다른 실시예에 따르면, 상기 각질제거용 화장료 조성물을 포함하는 각질제거용 패드에 관한 것이다. According to another embodiment of the present invention, it relates to a pad for exfoliating keratin containing the cosmetic composition for exfoliating keratin.
상기 패드는 당업자가 통상적으로 사용하는 패드로서, 각질제거용 화장료 조성물의 효과를 유지한다면 그 형태에 특별한 제한은 없다. The pad is a pad commonly used by those skilled in the art, and there is no particular limitation in its shape as long as the effect of the cosmetic composition for exfoliation is maintained.
상기 각질제거용 화장료 조성물은 항균 또는 항염, 항산화, 피지억제, 각질제거, 피부미백 및 보습을 위한 것일 수 있다. The cosmetic composition for removing keratin may be for antibacterial or anti-inflammatory, antioxidant, sebum inhibition, keratin removal, skin whitening and moisturizing.
본 명세서에서 용어 "화장료 조성물"은 인체를 청결, 미화하여 매력을 더하고 용모를 밝게 변화시키거나 피부, 모발의 건강을 유지 또는 증진하기 위하여 인체에 사용되는 물품을 의미한다. In this specification, the term "cosmetic composition" means an article used on the human body to clean and beautify the human body to add charm, brighten the appearance, or maintain or promote the health of skin and hair.
상기 피부는 얼굴, 손, 팔, 다리, 발, 가슴, 배, 등, 엉덩이 및 두피를 포함하는 신체의 모든 피부 부위를 포함한다. The skin includes all skin areas of the body including the face, hands, arms, legs, feet, chest, stomach, back, buttocks and scalp.
상기 각질제거용 화장료 조성물은 본 발명의 목적을 해하지 않는 내에서 용해제, 점증제, 방부제, 안정화제, 용해화제, 계면활성제, 담체, 및 향로로 이루어진 그룹에서 선택되는 어느 하나 이상을 포함하는 각질제거용 화장료 조성물일 수 있고, 또한 통상의 화장료에 배합되는 다른 성분 및 기능성 성분을 추가적으로 배합할 수도 있다. The cosmetic composition for exfoliating exfoliation includes at least one selected from the group consisting of a solubilizer, a thickener, an antiseptic, a stabilizer, a solubilizing agent, a surfactant, a carrier, and a fragrance, without compromising the object of the present invention. It may be a cosmetic composition for use, and other components and functional ingredients that are formulated in conventional cosmetics may be additionally formulated.
상기 화장료 조성물의 종류는 특별히 제한되지 않으나, 적합하게는 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐로션, 영양로션, 맛사지크림, 영양크림, 모이스쳐크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 이루어진 그룹에서 선택될 수 있고, 피부 외용제, 의약외품, 항균 또는 수분공급용 약학적 조성물로 이루어진 그룹에서 선택되는 어느 하나일 수 있다. The type of cosmetic composition is not particularly limited, but is preferably skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream, moisture cream, hand cream, foundation, It may be selected from the group consisting of essence, nutritional essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser, and selected from the group consisting of external skin preparations, quasi-drugs, antibacterial or pharmaceutical compositions for supplying moisture It can be any one of them.
상기 피부 외용제는 크림, 겔, 연고, 피부 유화제, 피부 현탁액, 경피전달성 패치, 약물 함유 붕대, 로션, 또는 그 조합일 수 있다. 상기 피부 외용제는 통상 화장품이나 의약품 등의 피부외용제에 사용되는 성분, 예를 들면 수성성분, 유성성분, 분말성분, 알코올류, 보습제, 증점제, 자외선흡수제, 미백제, 방부제, 산화방지제, 계면활성제, 향료, 색제, 각종 피부 영양제, 또는 이들의 조합과 필요에 따라서 적절하게 배합될 수 있다. 상기 피부외용제는, 에데트산이나트륨, 에데트산삼나트륨, 시트르산나트륨, 폴리인산나트륨, 메타인산나트륨, 글루콘산 등의 금속봉쇄제, 카페인, 탄닌, 벨라파밀, 감초추출물, 글라블리딘, 칼린의 과실의 열수추출물, 각종생약, 아세트산토코페롤, 글리틸리틴산, 트라넥삼산 및 그 유도체 또는 그 염등의 약제, 비타민 C, 아스코르브산인산마그네슘, 아스코르브산글루코시드, 알부틴, 코지산, 글루코스, 프룩토스, 트레할로스 등의 당류 등도 적절하게 배합할 수 있다. The external skin preparation may be a cream, gel, ointment, skin emulsifier, skin suspension, transdermal patch, drug-containing bandage, lotion, or a combination thereof. The skin external preparation is a component commonly used in external skin preparations such as cosmetics or pharmaceuticals, for example, water-based components, oil-based components, powder components, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, and fragrances. , colorants, various skin nutrients, or combinations thereof and may be suitably blended as needed. The external skin preparations include metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid, caffeine, tannin, bellapamil, licorice extract, glabridin, and calin. Hot-water extracts of fruits, various herbal medicines, tocopherol acetate, glycyrrhizic acid, tranexamic acid and its derivatives or salts and other drugs, vitamin C, magnesium ascorbate phosphate, ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, Sugars, such as trehalose, etc. can also be mix|blended suitably.
이하, 본 발명을 하기의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다. Hereinafter, the present invention will be described in detail by the following examples. However, the following examples are only to illustrate the present invention, and the content of the present invention is not limited by the following examples.
실시예Example
실험예 1: LHA 및 폴리에틸렌 글라이콜 에테르에 따른 효능평가 Experimental Example 1: Efficacy evaluation according to LHA and polyethylene glycol ether
살리실릭 애씨드capryloyl
salicylic acid
상기 표 1에서 보는 바와 같이, 실시예 1 및 비교예 1 내지 4의 각 성분 및 잔부의 정제수를 포함하는 각질제거용 화장료 조성물을 제조하여 pH, 제형의 용해여부 및 안정도평가를 실시하여 하기 표 2에 나타내었다. As shown in Table 1, a cosmetic composition for exfoliation containing each component of Example 1 and Comparative Examples 1 to 4 and the remaining purified water was prepared, and pH, dissolution of the formulation and stability were evaluated, and the following Table 2 shown in
구체적으로 상기 표 1의 조성으로 제조된 각질제거용 화장료 조성물의 pH는 pH측정기를 이용하였으며, 내용물이 충분히 섞이도록 10회 흔든 뒤, 용해여부 및 안정도의 평가는 육안관찰로 이루어졌다. Specifically, the pH of the cosmetic composition for exfoliation prepared with the composition of Table 1 was measured using a pH meter, shaken 10 times to sufficiently mix the contents, and then evaluated for dissolution and stability by visual observation.
상기 표 2에서 보는 바와 같이, 실시예 1은 각질제거용 화장료 조성물로서 적합하며 비교예 1 내지 4는 부적합한 것을 확인할 수 있었다. As shown in Table 2, Example 1 was suitable as a cosmetic composition for removing dead skin cells, and Comparative Examples 1 to 4 were found to be unsuitable.
구체적으로, 실시예 1은 LHA가 완전히 용해되어 석출되지 않으며, 목적하는 pH의 범위를 유지하는 것을 확인할 수 있었다. Specifically, in Example 1, it was confirmed that LHA was not completely dissolved and precipitated and maintained within the desired pH range.
비교예 1은 LHA를 0.18 중량% 혼합한 경우로, 실시예 1과 대비하여 용해여부 및 안정도는 유사한 것을 확인할 수 있었으나, pH의 값이 목적하는 범위를 벗어나는 것을 알 수 있었다. 이에 따라 실시예 1 및 비교예 1을 대비해보면, LHA의 함량이 0.2 중량% 미만으로 포함되는 경우 목적하는 pH의 범위를 유지하지 못하는 문제점이 있으며 본 발명에 따라 LHA를 0.2 중량% 이상 포함하는 경우 불필요한 과잉 각질만을 제거하여 최소한의 자극으로 피지 및 각질제거의 기능을 할 수 있음을 알 수 있다. In Comparative Example 1, when 0.18% by weight of LHA was mixed, it was confirmed that dissolution and stability were similar to Example 1, but it was found that the pH value was outside the desired range. Accordingly, comparing Example 1 and Comparative Example 1, when the LHA content is less than 0.2% by weight, there is a problem of not maintaining the desired pH range, and according to the present invention, when the LHA is included at 0.2% by weight or more It can be seen that the function of sebum and dead skin removal can be performed with minimal stimulation by removing only unnecessary and excessive dead skin cells.
비교예 2 및 3은 C12-14파레스-12의 함량비를 다르게 포함한 경우로, C12-14파레스-12를 포함하지 않은 비교예 2는 LHA가 완전히 용해되지 않아 정제수와 만날 경우 석출되어 완전히 분리되는 것을 도 1을 통하여 확인할 수 있었다. 또한 C12-14파레스-12를 0.45 중량% 혼합한 비교예 3의 경우도 LHA가 완전히 용해되지 않아 석출되는 것을 확인할 수 있었다. 이에 따라 비교예 2 및 3을 실시예 1과 대비하면 C12-14파레스-12의 함량비가 높아짐에 따라 용해도 및 안정도가 증가하며, 본 발명에 따라 C12-14파레스-12를 0.5 중량% 이상 포함하는 경우 생산성 및 경제적으로 효율적인 측면에서 임계적 의의가 있는 것을 알 수 있다. 또한, 비교예 2 및 3의 경우 LHA가 완전히 용해되지 않고 석출되므로 pH의 측정이 무의미한 것으로 측정하지 않았다. Comparative Examples 2 and 3 include different content ratios of C12-14 Pareth-12, and Comparative Example 2, which does not contain C12-14 Pareth-12, does not completely dissolve LHA and precipitates when it meets purified water and is completely separated. It was confirmed through Figure 1. In addition, in the case of Comparative Example 3 in which 0.45% by weight of C12-14 Pareth-12 was mixed, it was confirmed that LHA was not completely dissolved and precipitated. Accordingly, when Comparative Examples 2 and 3 are compared with Example 1, the solubility and stability increase as the content ratio of C12-14 Pareth-12 increases, and according to the present invention, C12-14 Pareth-12 containing 0.5% by weight or more In this case, it can be seen that there is a critical significance in terms of productivity and economical efficiency. In addition, in the case of Comparative Examples 2 and 3, since LHA was not completely dissolved and precipitated, the measurement of pH was not measured as meaningless.
비교예 4는 본원발명의 폴리에틸렌 글라이콜 에테르인 C12-14파레스-12와 다른 종류의 안정화제를 혼합한 경우이다. 구체적으로 비교예 4는 POLYGLYCERYL-10 LAURATE 0.5중량%를 혼합한 경우로, 완전히 용해되지만 pH 7.12로 목적하는 pH의 범위를 벗어나는 것을 알 수 있었다. Comparative Example 4 is a case in which C12-14 Pareth-12, which is the polyethylene glycol ether of the present invention, is mixed with a different type of stabilizer. Specifically, in Comparative Example 4, when 0.5% by weight of POLYGLYCERYL-10 LAURATE was mixed, it was found that it was completely dissolved but outside the desired pH range at pH 7.12.
따라서 LHA 및 안정화제로서 폴리에틸렌 글라이콜 에테르인 C12-14파레스-12를 본 발명에 따른 실시예 1의 배합비로 포함하였을 경우, 각 조성물들이 모두 용해되어 석출되지 않아 각질제거용 화장료 조성물로서 형성이 가능하고, 목적하는 pH의 범위를 유지하여 피부에 자극을 최소한으로 하면서도 피지 및 각질케어가 가능한 것을 확인할 수 있었다. Therefore, when LHA and polyethylene glycol ether C12-14 Pareth-12 as a stabilizer were included in the mixing ratio of Example 1 according to the present invention, each composition was not dissolved and precipitated, so it was formed as a cosmetic composition for exfoliation. It was confirmed that sebum and keratin care was possible while minimizing irritation to the skin by maintaining the desired pH range.
실험예 2: 안정화제에 따른 용해도평가Experimental Example 2: Solubility evaluation according to stabilizer
2-1: 폴리올의 종류에 따른 용해도평가2-1: Solubility evaluation according to the type of polyol
(카프릴로일 살리실릭 애씨드)LHA
(Capryloyl Salicylic Acid)
polyol
상기 표 3에서 보는 바와 같이, 비교예 5 내지 6의 각 성분 및 잔부의 정제수를 포함하는 각질제거용 화장료 조성물을 제조하여 제형의 용해여부 및 안정도평가를 실시하여 하기 표 4에 나타내었다. As shown in Table 3, a cosmetic composition for exfoliation containing each component of Comparative Examples 5 to 6 and the balance of purified water was prepared, and the dissolution and stability of the formulation were evaluated, and the results are shown in Table 4 below.
구체적으로 상기 표 3의 조성으로 제조된 각질제거용 화장료 조성물의 내용물이 충분히 섞이도록 10회 흔든 뒤, 육안관찰로 용해여부 및 안정도의 평가를 수행하였다. Specifically, after shaking 10 times so that the contents of the cosmetic composition for exfoliation prepared with the composition of Table 3 were sufficiently mixed, dissolution and stability were evaluated by visual observation.
상기 표 4에서 보는 바와 같이, 디프로필렌 글라이콜이 아닌 다른 폴리올을 사용한 비교예 5 내지 7 모두 LHA가 완전히 용해되지 않아 석출되는 것을 확인할 수 있었다. As shown in Table 4, it was confirmed that LHA was not completely dissolved and precipitated in Comparative Examples 5 to 7 using a polyol other than dipropylene glycol.
구체적으로, 폴리올을 포함하지 않은 비교예 5, 메칠프로판디올을 포함한 비교예 6(도 2 참조) 및 글리세린을 포함한 비교예 7(도 3 참조)의 경우 LHA가 완전하게 용해되지 않아 정제수와 만날 경우 석출되어 분리되는 것을 확인할 수 있었다. 따라서 LHA를 용해시키기 위한 폴리올이 필요한 것을 알 수 있다. Specifically, in the case of Comparative Example 5 without polyol, Comparative Example 6 including methylpropanediol (see FIG. 2) and Comparative Example 7 including glycerin (see FIG. 3), when LHA is not completely dissolved and meets purified water It was confirmed that it precipitated and separated. Therefore, it can be seen that a polyol is required to dissolve LHA.
따라서, 상기 표 3 내지 4, 도 2 및 3에서 확인할 수 있듯, 본 발명에 따른 디프로필렌 글라이콜이 아닌 다른 종류의 폴리올을 사용할 경우, LHA를 전혀 용해시키지 못하여 화장료 조성물의 제형으로서 형성이 불가능한 것을 알 수 있었다. Therefore, as can be seen in Tables 3 to 4 and FIGS. 2 and 3, when using a polyol other than the dipropylene glycol according to the present invention, LHA cannot be dissolved at all, making it impossible to form a cosmetic composition formulation. could find out
2-2: 디프로필렌 글라이콜의 적정중량비에 대한 평가2-2: Evaluation of proper weight ratio of dipropylene glycol
상기 표 5에서 보는 바와 같이, 실시예 2 및 비교예 8의 각 성분 및 잔부의 정제수를 포함하는 각질제거용 화장료 조성물을 제조하여 제형의 용해여부 및 안정도평가를 실시하여 하기 표 6에 나타내었다. As shown in Table 5, a cosmetic composition for exfoliation containing purified water of each component and balance of Example 2 and Comparative Example 8 was prepared, and the dissolution and stability of the formulation were evaluated, and the results are shown in Table 6 below.
구체적으로 상기 표 5의 조성으로 제조된 각질제거용 화장료 조성물의 내용물이 충분히 섞이도록 10회 흔든 뒤, 육안관찰로 용해여부 및 안정도의 평가를 수행하였다. Specifically, after shaking 10 times so that the contents of the cosmetic composition for exfoliation prepared with the composition of Table 5 were sufficiently mixed, dissolution and stability were evaluated by visual observation.
상기 표 5 내지 6에서 보는 바와 같이, 디프로필렌 글라이콜을 7중량% 이상 혼합한 경우 LHA가 완전히 용해되어 화장료 조성물로서 형성이 가능한 것을 확인할 수 있었다. As shown in Tables 5 to 6, when 7% by weight or more of dipropylene glycol was mixed, it was confirmed that LHA was completely dissolved and formed as a cosmetic composition.
구체적으로, 비교예 8은 디프로필렌 글라이콜이 7중량% 미만으로 혼합된 경우로, LHA가 완전하게 용해되지 않아 정제수와 만날 경우 석출되어 분리되는 것을 도 4를 통하여 확인할 수 있었다. 또한 비교예 8을 실시예 1 및 2와 대비하면 디프로필렌 글라이콜을 7중량% 이상 혼합될 경우 디프로필렌 글라이콜의 함량비가 증가함에 따른 효과의 차이가 현저하게 나타나지 않는 것을 알 수 있다. Specifically, in Comparative Example 8, when dipropylene glycol was mixed at less than 7% by weight, it was confirmed through FIG. 4 that LHA was not completely dissolved and precipitated and separated when meeting purified water. In addition, when Comparative Example 8 is compared with Examples 1 and 2, it can be seen that when 7% by weight or more of dipropylene glycol is mixed, the difference in effect due to the increase in the content ratio of dipropylene glycol does not appear significantly.
이에 따라, 본 발명의 함량비에 따라 디프로필렌 글라이콜을 7 중량% 이상 사용할 경우, 생산성 및 경제적인 측면에서 효율적인 화장료 조성물을 제조할 수 있는 임계적 의의가 있음을 확인할 수 있었다. Accordingly, it was confirmed that when dipropylene glycol is used in an amount of 7% by weight or more according to the content ratio of the present invention, there is a critical significance in producing an efficient cosmetic composition in terms of productivity and economy.
2-3: 트로메타민의 적정중량비에 대한 평가2-3: Evaluation of proper weight ratio of tromethamine
상기 표 7은 트로메타민의 함량비에 따른 pH 및 안정도 평가를 나타낸 것이다. 구체적으로 비교예 9 내지 12의 트로메타민의 함량비를 제외한 다른 성분들의 함량비는 실시예 1과 동일하게 제조하였으며, 잔부의 정제수를 포함하였다. 또한, pH측정기를 이용하여 제조 직후의 화장료 조성물에 대한 pH 및 온도변화에 따른 2주차의 화장료 조성물에 대한 pH를 평가하였다. 또한, 안정도의 평가는 육안관찰로 이루어졌다. Table 7 shows the evaluation of pH and stability according to the content ratio of tromethamine. Specifically, the content ratios of other components except for the content ratio of tromethamine in Comparative Examples 9 to 12 were prepared in the same manner as in Example 1, and the remainder included purified water. In addition, the pH of the cosmetic composition of the second week according to the pH and temperature change of the cosmetic composition immediately after preparation was evaluated using a pH meter. In addition, evaluation of stability was made by visual observation.
상기 표 7에서 보는 바와 같이, 트로메타민의 함량비가 증가할수록 pH의 값이 증가하는 것을 알 수 있으며 트로메타민이 0.13 중량% 이상 포함될 경우 목적하는 pH의 범위를 유지하지 못하여 각질 제거 효능이 약해지는 것을 알 수 있다. 또한, 비교예 12는 트로메타민의 함량이 0.18 중량%를 초과하는 경우로, pH의 값이 현저히 높아지며 미세황변이 발생하는 것을 확인할 수 있었다. As shown in Table 7, it can be seen that the pH value increases as the content ratio of tromethamine increases, and when tromethamine is included in an amount of 0.13% by weight or more, the desired pH range is not maintained and the exfoliation efficacy is weakened. Able to know. In Comparative Example 12, when the tromethamine content exceeded 0.18% by weight, it was confirmed that the pH value was significantly increased and micro-yellowing occurred.
또한, 제조직후의 pH와 온도변화에 따른 2주차에서의 pH값을 대비하면 온도 변화에 따른 pH의 변화는 현저하게 적은 것을 확인할 수 있었다. In addition, when comparing the pH value immediately after production and the pH value at 2 weeks according to the temperature change, it was confirmed that the change in pH according to the temperature change was remarkably small.
이에 따라 본 발명의 함량비에 따른 트로메타인을 사용할 경우, 미세황변 현상이 발생하지 않으며, 가장 적합하게는 실시예 1에 따른 함량에서 목적하는 pH의 범위를 유지하여 각질제거 효능이 우수한 화장료 조성물을 제조할 수 있었다. Accordingly, when tromethane according to the content ratio of the present invention is used, micro-yellowing does not occur, and most preferably, a cosmetic composition with excellent exfoliation efficacy by maintaining the desired pH range at the content according to Example 1 was able to manufacture
실험예 3: 시간의 경과 및 온도변화에 대한 pH 및 안정도 평가Experimental Example 3: Evaluation of pH and stability over time and temperature change
상기 표 8은 실시예 1의 각 성분 및 잔부의 정제수를 포함하는 각질제거용 화장료 조성물을 이용하여 시간의 경과 및 온도변화에 따른 pH 및 안정도를 평가한 것이다. Table 8 is an evaluation of the pH and stability according to the passage of time and temperature change using the cosmetic composition for exfoliation containing each component and the balance of purified water of Example 1.
구체적으로 각 온도별로 시간이 경과하였을 경우 pH값의 변화는 현저하게 적은 것을 확인할 수 있다. 또한 본 발명의 함량비에 따라 각질제거용 화장료 조성물을 제조할 경우 온도에 따른 pH값의 차이도 현저하게 적으며, 목적하는 pH의 범위를 유지하면서도 안정적인 것을 확인할 수 있다. 따라서 시간의 경과 및 온도변화에 따른 pH 값과 안정도는 차이가 현저하게 적은 것을 알 수 있었다. Specifically, it can be confirmed that the change in pH value is remarkably small when time elapses for each temperature. In addition, when preparing the cosmetic composition for exfoliation according to the content ratio of the present invention, the difference in pH value according to the temperature is remarkably small, and it can be confirmed that it is stable while maintaining the desired pH range. Therefore, it was found that the difference in pH value and stability according to the passage of time and temperature change was remarkably small.
이에 따라, 본 발명의 배합비로 제조하는 경우, 목적하는 pH의 범위를 유지하면서도 안정성이 높은 화장료 조성물을 제조할 수 있는 임계적 의의가 있음을 확인할 수 있었다. Accordingly, it was confirmed that there is a critical significance in preparing a cosmetic composition with high stability while maintaining the desired pH range when prepared with the compounding ratio of the present invention.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다. Having described specific parts of the present invention in detail above, it is clear that these specific techniques are only preferred embodiments for those skilled in the art, and the scope of the present invention is not limited thereto. Accordingly, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
Claims (10)
상기 LHA는 상기 각질제거 화장료 조성물 전체 중량에 대하여, 0.2 내지 2 중량% 포함되는 각질제거용 화장료 조성물. According to claim 1,
The LHA is 0.2 to 2% by weight relative to the total weight of the exfoliating cosmetic composition.
상기 LHA는 카프릴로일 살리실릭 애씨드(Capryloyl Salicylic Acid)인 것을 특징으로 하는 각질제거용 화장료 조성물. According to claim 1,
The LHA is a cosmetic composition for exfoliation, characterized in that capryloyl salicylic acid (Capryloyl Salicylic Acid).
상기 폴리에틸렌 글라이콜 에테르는 상기 각질제거 화장료 조성물 전체 중량에 대하여, 0.5 중량% 이상 포함되는 각질제거용 화장료 조성물. According to claim 1,
The polyethylene glycol ether is a cosmetic composition for removing dead skin cells containing 0.5% by weight or more based on the total weight of the cosmetic composition for removing dead skin cells.
상기 폴리에틸렌 글라이콜 에테르는 C12-14 파레스-12인 것을 특징으로 하는 각질제거용 화장료 조성물. According to claim 1,
The polyethylene glycol ether is a cosmetic composition for exfoliation, characterized in that C12-14 Pares-12.
상기 안정화제는 디프로필렌 글라이콜(Dipropylene Glycol) 및 트로메타민(Tromethamine)으로 이루어진 그룹에서 선택되는 어느 하나 이상을 더 포함하는 각질제거용 화장료 조성물. According to claim 1,
The stabilizer is dipropylene glycol And tromethamine (Tromethamine) a cosmetic composition for exfoliation further comprising any one or more selected from the group consisting of.
상기 디프로필렌 글라이콜은 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 7 중량% 이상으로 포함되는 각질제거용 화장료 조성물. According to claim 6,
The dipropylene glycol is a cosmetic composition for exfoliation containing 7% by weight or more based on the total weight of the cosmetic composition for exfoliation.
상기 트로메타민은 상기 각질제거용 화장료 조성물 전체 중량에 대하여, 0.12 중량% 이하로 포함되는 각질제거용 화장료 조성물. According to claim 6,
The tromethamine is contained in an amount of 0.12% by weight or less based on the total weight of the cosmetic composition for removing keratin.
상기 각질제거용 화장료 조성물은 pH 5 내지 6인 것을 특징으로 하는 각질제거용 화장료 조성물. According to claim 1,
The cosmetic composition for exfoliation is a cosmetic composition for exfoliation, characterized in that the pH 5 to 6.
A pad for removing dead skin cells comprising the cosmetic composition for removing dead skin cells according to any one of claims 1 to 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210145116A KR102670049B1 (en) | 2021-10-28 | 2021-10-28 | Cosmetic composition for exfoliating and pad having the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210145116A KR102670049B1 (en) | 2021-10-28 | 2021-10-28 | Cosmetic composition for exfoliating and pad having the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20230060659A true KR20230060659A (en) | 2023-05-08 |
| KR102670049B1 KR102670049B1 (en) | 2024-05-28 |
Family
ID=86381685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210145116A KR102670049B1 (en) | 2021-10-28 | 2021-10-28 | Cosmetic composition for exfoliating and pad having the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102670049B1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030066874A (en) * | 2002-02-05 | 2003-08-14 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Lactate and Vitamin C for Skin Whitening |
| KR20100013519A (en) * | 2008-07-31 | 2010-02-10 | 주식회사 엘지생활건강 | Composition comprising pure vitamin c for whitening |
| KR20120058850A (en) * | 2010-11-30 | 2012-06-08 | 주식회사 알엔에스 | Compositions for the antiinflammatory and the antimicrobial activities |
| KR20210100975A (en) | 2020-02-07 | 2021-08-18 | 코스맥스 주식회사 | Transparent cosmetic composition for cleansing |
-
2021
- 2021-10-28 KR KR1020210145116A patent/KR102670049B1/en active IP Right Grant
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030066874A (en) * | 2002-02-05 | 2003-08-14 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Lactate and Vitamin C for Skin Whitening |
| KR20100013519A (en) * | 2008-07-31 | 2010-02-10 | 주식회사 엘지생활건강 | Composition comprising pure vitamin c for whitening |
| KR20120058850A (en) * | 2010-11-30 | 2012-06-08 | 주식회사 알엔에스 | Compositions for the antiinflammatory and the antimicrobial activities |
| KR20210100975A (en) | 2020-02-07 | 2021-08-18 | 코스맥스 주식회사 | Transparent cosmetic composition for cleansing |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102670049B1 (en) | 2024-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1667699B1 (en) | Compositions comprising lotus extracts and methyl donors | |
| US20060165644A1 (en) | Cosmetics | |
| KR101972071B1 (en) | Cosmetic composition for improving skin tone or skin elasticity | |
| JPH0940523A (en) | Fibroblast proliferation promoter containing water extract form chlorella | |
| WO2002047656A1 (en) | Compositions for retarding skin aging | |
| KR20110131498A (en) | Extracted from the shell containing the antimicrobial silver ions in alkaline solution and its composition, including manufactured | |
| TWI682782B (en) | Methods and compositions for topical delivery for skin care | |
| KR20110086894A (en) | Cosmetic included to alkaline powder & solution of shell | |
| CN106727148A (en) | Facial mask and preparation method thereof is repaired in a kind of dendrobium candidum moisturizing | |
| KR102307509B1 (en) | Composition for hairloss and scalp care | |
| KR100947638B1 (en) | Composition comprising lava seawater salt | |
| KR20070117355A (en) | Skin topical composition containing placenta extract | |
| KR20160131387A (en) | Composition for skin care | |
| JP3784962B2 (en) | Hair growth inhibitor | |
| ES2400284T3 (en) | Mixes with a stimulating action of collagen synthesis | |
| KR100861186B1 (en) | Cosmetic for preventing and treating acnes containing Cryptotanshinone | |
| JP2005047910A (en) | Sebum secretion-inhibiting composition | |
| KR20200073970A (en) | Soothing cream and manufacturing method for the same | |
| KR20080049328A (en) | Cosmetic compositions to stabilize ascorbic acid | |
| JPH11240817A (en) | Beauty culture pack | |
| KR102383715B1 (en) | Cosmetic composition having weak-acidity and low-viscosity with excellent suppressing sebum and stability | |
| KR102670049B1 (en) | Cosmetic composition for exfoliating and pad having the same | |
| KR20150116504A (en) | A cosmetics composition containing tea tree and solt | |
| KR100574233B1 (en) | Cosmetic composition comprising plant extract having moisturizing and anti-irritating activity | |
| JP4169814B2 (en) | A topical skin preparation containing agave or sisal extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |